GLP-1 medications typically begin lowering blood glucose within 1-2 weeks of starting treatment, though optimal glycemic control usually requires 12-16 weeks as the dose is gradually increased
Nutrition Vital When Taking GLP-1 Weight Loss Drugs. UCHealth Today, 19 May 2025
Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimers disease dementia
Following the completion of these trials, the developer is expected to submit a New Drug Application (NDA) to the FDA in early 2027
If latter, working with therapist to process this may be valuable before making decisions
Monami M, Nreu B, Scatena A, Cresci B, Andreozzi F, Sesti G, et al